|
|
 |
|
Viewing report
|
|
|
|
Pharmaceutical Anti-Counterfeiting: Combating the Real Danger from Fake Drugs
John Wiley and Sons Ltd, Aug 2011, Pages: 426
The scourge of counterfeit drugs poses an ever-increasing threat to the global healthcare system. The problem is not limited to internet pharmacies or developing countries but has the potential to affect all of us. Fighting back against fake and diverted medicines requires a mix of laws, processes and technologies, underpinned by a sound understanding of the strategic principles. There are already a number of major initiatives to increase the traceability of drugs and improve supply chain security, such as serialization, e-pedigree, SMS verification etc. Some of these will become mandatory requirements (for example in Europe and California) within a few years. Individual companies also put security features on their packaging to aid in the authentication of their products when suspected fake drugs are identified. The number of technology options and legal obligations can be confusing and clear guidance has been hard to come by.
This book overviews and integrates the business and technical issues that pharmaceutical companies need to know in order to combat the major global problem of counterfeit medicines. In addition to discussion of the problems, the author Davison addresses analytical techniques scientists use to detect counterfeits and presents some possible solutions to the threat of counterfeit medical products.
Coverage moves from basic overview of the problem, costs / risks to consumers (toxic products, mistrust of drug companies) and business (revenue loss, public trust), government oversight and regulation, authentication strategies (packaging, analytical techniques), product tracking and supply chain, and case studies from around the globe.
Review:
'Cambridge-based consultant and entrepreneur Mark Davison, CEO of Blue Sphere Health Ltd, has written a comprehensive guide for drug company executives, technology vendors, healthcare professionals and policy-makers. . . This newly-released 426pp volume is a must-read primer for those determined to do something about counterfeit pharmaceutical and healthcare products, and will prove useful to brand protection professionals in other industries.'
-- Cambridge Network , 6 September 2011
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
